Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2024LeukemiaOpen Access

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHayden L. BellHBHelen J. BlairSGSamantha J. Jepson Gosling

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bell et al. (2024) studied this question.

synapsesocial.com/papers/68e6f97db6db643587674301https://doi.org/10.1038/s41375-024-02241-7
View Full Paper
Ask AI
Bookmark
Share